recurrent ovarian cancer - Globe Thesis

Keyword [recurrent ovarian cancer] Result: 41 - 60 \| Page: 3 of 4
41.	Clinical Efficacy Of CIK Combined With TP Regimen In The Treatment Of Recurrent Ovarian Cancer
42.	Factors Influencing The Efficacy Of Secondary Cytoreductive Surgery For Platinum Sensitive Recurrent Ovarian Cancer
43.	Analysis Of The Clinica And Pathologica Factors Affecting The Treatment Effect Of Platinum-sensitive Recurret Ovarian Cancer
44.	The Adverse Events Of Bevacizumab In Combination With Chemotherapy For Recurrent Ovarian Cancer:a Meta Analysis
45.	The Prognosis Of Hyerthermic Intraperitoneal Chemotherapy For Recurrent Ovarian Cancer:a Meta-analysis
46.	Meta-analysis Of The Efficacy And Safety Of PARP Inhibitors In The Maintenance Of Recurrent Ovarian Cancer
47.	Pre-evaluation Of Satisfaction Degree With Secondary Cytoreductive Surgery For Platinum-sensitive Recurrent Ovarian Cancer
48.	The Analysis Of The Physical Distrubution Of Recurrent Ovarian Cancer Patients And Its Clinical Factors
49.	Clinical Characteristics And Analysis Of Prognosis Factors Of 93 Cases Of Recurrent Ovarian Cancer
50.	The Short-term Efficacy Analysis Of Albumin-bound Paclitaxel In The Treatment Of Recurrent Ovarian Cancer
51.	1 A Study Of Efficacy And Its Correlation With Plasma Biomarkers For Platinum-Resistant Recurrent Ovarian Cancer Patients Treated With PLD Combined With Apatinib Or PLD Alone 2 An Exploratory Analysis About Cycles Of Adjuvant Chemotherapy And Outcomes By
52.	Evaluation Of The Efficacy And Safety Of PARP Inhibitors In The Treatment Of Recurrent Ovarian Cancer
53.	Bevacizumab In The Treatment Of Recurrent Ovarian Cancer:a Retrospective Study And Meta-analysis
54.	Targeted Agents In Combination With Chemotherapy For Recurrent Ovarian Cancer:An Updated Systematic Review And Meta-Analysis
55.	Comparing And Analyzing The Prognosis Of Platinum-sensitive Recurrent Ovarian Cancer With Secondary Cytoreductive Surgery Combined With Chemotherapy And Simple Chemotherapy
56.	Analysis Of The Effectiveness And Safety Of Olaparib In Maintenance Treatment Of Platinum-sensitive Recurrent Ovarian Cancer
57.	The Study Of The Therapeutic Of Secondary Cytoreduction Surgery In Patients With Platinum Sensitive Recurrent Ovarian Cancer With Unsatisfactory Primary Cytoreduction Surgery
58.	Clinical Observation Of Yiqi Yangyin Tongluo Formula Combined With Anlotinib In The Treatment Of Platinum-resistant Recurrent Ovarian Cancer
59.	Clinical Study Of Albumin-bound Paclitaxel In The Treatment Of Recurrent Ovarian Cancer
60.	Efficacy And Safety Of VEGFR-TKIs In Advanced And Recurrent Ovarian Cancer:A Meta-analysis
<<First <Prev Next> Last>> Jump to